Last 7 days
0.3%
Last 30 days
78.3%
Last 90 days
54.0%
Trailing 12 Months
43.7%
Datesorted ascending | Name | Buy/Sell | $ Value | Avg. Price | # Shares | Title |
---|---|---|---|---|---|---|
2023-08-14 | Struthers Richard Scott | acquired | 19,100 | 1.91 | 10,000 | president & ceo |
2023-07-13 | Struthers Richard Scott | sold | -288,095 | 20.35 | -14,157 | president & ceo |
2023-07-12 | Struthers Richard Scott | sold | -231,128 | 20.17 | -11,459 | president & ceo |
2023-07-11 | Struthers Richard Scott | sold | -491,094 | 20.14 | -24,384 | president & ceo |
2023-06-20 | Wilson Marc | acquired | 185,600 | 9.28 | 20,000 | cfo |
2023-06-20 | Wilson Marc | sold | -617,403 | 19.9665 | -30,922 | cfo |
2023-06-16 | Vivaldi Coelho Rogerio | acquired | - | - | 6,000 | - |
2023-06-16 | Struthers Richard Scott | sold | -1,040,500 | 20.81 | -50,000 | president & ceo |
2023-06-16 | Okey Stephanie | acquired | - | - | 6,000 | - |
2023-06-16 | Nichols Weston | acquired | - | - | 6,000 | - |
Datesorted ascending | Fund Name | Type | % Chg | $ Change | $ Held | % Portfolio |
---|---|---|---|---|---|---|
2023-08-24 | PERCEPTIVE ADVISORS LLC | reduced | -45.23 | -22,007,700 | 35,083,800 | 1.01% |
2023-08-21 | CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | reduced | -3.27 | 72,212 | 917,867 | -% |
2023-08-21 | OSAIC HOLDINGS, INC. | added | 382 | 35,432 | 43,461 | -% |
2023-08-21 | TEACHERS RETIREMENT SYSTEM OF THE STATE OF KENTUCKY | reduced | -27.17 | -142,000 | 635,000 | 0.01% |
2023-08-16 | Nuveen Asset Management, LLC | added | 176 | 4,187,090 | 6,184,090 | -% |
2023-08-15 | GOLDMAN SACHS GROUP INC | added | 18.19 | 2,725,150 | 11,079,500 | -% |
2023-08-15 | WELLS FARGO & COMPANY/MN | added | 42.44 | 297,710 | 795,313 | -% |
2023-08-15 | ALLIANCEBERNSTEIN L.P. | unchanged | - | 100,352 | 922,624 | -% |
2023-08-15 | NATIXIS ADVISORS, L.P. | added | 0.82 | 42,000 | 367,000 | -% |
2023-08-15 | EVENTIDE ASSET MANAGEMENT, LLC | unchanged | - | 852,145 | 7,834,520 | 0.13% |
Date Filed | Name of Filer | Percent of Class | No. of Shares | Form Type | |
---|---|---|---|---|---|
Sep 18, 2023 | point72 asset management, l.p. | 5.6% | 3,719,200 | SC 13G | |
Feb 14, 2023 | braidwell lp | 6.45% | 3,469,674 | SC 13G | |
Feb 14, 2023 | biotechnology value fund l p | 2.7% | 1,447,317 | SC 13G/A | |
Feb 14, 2023 | orbimed advisors llc | 5.0% | 2,710,710 | SC 13G/A | |
Feb 09, 2023 | fmr llc | - | 0 | SC 13G/A | |
Feb 08, 2023 | driehaus capital management llc | 10.45% | 5,624,744 | SC 13G/A | |
Feb 06, 2023 | wellington management group llp | 5.21% | 2,804,485 | SC 13G | |
Jan 31, 2023 | blackrock inc. | 7.3% | 3,917,489 | SC 13G/A | |
Apr 26, 2022 | perceptive advisors llc | 10.0% | 5,333,532 | SC 13D/A | |
Apr 21, 2022 | perceptive advisors llc | 10.0% | 5,333,532 | SC 13D/A |
Date Filed | Form Type | Document | |
---|---|---|---|
Sep 18, 2023 | SC 13G | Major Ownership Report | |
Sep 13, 2023 | 424B5 | Prospectus Filed | |
Sep 13, 2023 | 8-K | Current Report | |
Sep 11, 2023 | 424B5 | Prospectus Filed | |
Sep 11, 2023 | 8-K | Current Report | |
Aug 16, 2023 | 4 | Insider Trading | |
Aug 08, 2023 | 10-Q | Quarterly Report | |
Aug 08, 2023 | 8-K | Current Report | |
Jul 13, 2023 | 144 | Notice of Insider Sale Intent | |
Jul 13, 2023 | 4 | Insider Trading |
Name | Mkt Capsorted ascending | Revenue | Price %, 1M | Returns, 1Y | P/E | P/S | Rev 1-Yr | Inc 1-Yr |
---|---|---|---|---|---|---|---|---|
LARGE-CAP | ||||||||
ABBV | 271.4B | 56.0B | 2.30% | 9.45% | 31.25 | 4.84 | -2.31% | -31.27% |
BGNE | 265.4B | 1.8B | -1.67% | 25.43% | -153.19 | 146.56 | 69.45% | 14.65% |
VRTX | 90.8B | 9.5B | 0.45% | 22.78% | 26.99 | 9.56 | 13.83% | 5.33% |
REGN | 89.0B | 12.7B | -1.51% | 18.09% | 20.7 | 7.02 | -10.94% | -24.40% |
ALNY | 21.9B | 1.2B | -7.00% | -17.21% | -20.61 | 17.72 | 39.94% | -8.44% |
SRPT | 11.0B | 1.0B | 3.70% | 3.57% | -12.12 | 10.97 | 20.15% | -79.16% |
UTHR | 10.5B | 2.1B | -3.12% | 8.08% | 12.05 | 4.98 | 18.01% | 38.16% |
MID-CAP | ||||||||
BPMC | 3.1B | 225.6M | 0.04% | -28.00% | -5.53 | 13.59 | -2.11% | 21.02% |
MDGL | 3.0B | - | -10.01% | 147.80% | -9.03 | - | - | -28.88% |
RARE | 2.6B | 402.9M | -2.14% | -20.15% | -3.59 | 6.42 | 20.50% | -42.46% |
MRTX | 1.9B | 27.2M | -14.18% | -57.07% | -2.57 | 69.63 | - | -14.43% |
SMALL-CAP | ||||||||
CYTK | 3.1B | - | -2.94% | -39.70% | -7.31 | 33.28 | 34.30% | -149.91% |
CPRX | 1.3B | 302.9M | -16.58% | -4.84% | 11.23 | 4.28 | 77.72% | 112.02% |
MGNX | 281.2M | 152.5M | -11.67% | 38.41% | 37.75 | 1.84 | 127.84% | 103.41% |
CRBP | 29.9M | - | 1.35% | 3552.08% | -0.65 | - | - | -31.51% |
-1.7%
22.0%
100%
85.4%
53.9%
Y-axis is the maximum loss one would have experienced if Crinetics Pharmaceuticals was unfortunately bought at previous high price.
Income Statement (Last 12 Months) | ||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Description | (%) Q/Q | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 | 2018Q4 | 2018Q3 | 2018Q2 | 2018Q1 | 2017Q4 | 2017Q3 |
Revenue | 12.8% | 4,834,000 | 4,285,000 | 4,737,000 | 5,370,667 | 7,140,000 | 12,524,000 | 1,078,000 | 735,000 | 392,000 | 897,000 | 897,000 | 1,193,000 | 1,653,000 | 1,696,000 | 2,353,000 | 2,428,000 | 2,175,000 | 2,267,000 | 2,442,000 | 2,071,400 | 1,700,800 |
Operating Expenses | 5.6% | 196,817,000 | 186,318,000 | 172,619,000 | 156,320,000 | 140,215,000 | 122,820,000 | 108,780,000 | 75,024,000 | 68,768,000 | 66,051,000 | 62,467,000 | 55,025,000 | 49,702,000 | 42,586,000 | 35,581,000 | 31,138,000 | 23,955,000 | 18,351,000 | 14,486,000 | 11,172,000 | 10,857,333 |
S&GA Expenses | 6.2% | 48,731,000 | 45,877,000 | 42,394,000 | 38,482,000 | 32,784,000 | 27,897,000 | 24,525,000 | 18,026,000 | 16,457,000 | 15,616,000 | 14,354,000 | 13,519,000 | 12,688,000 | 10,509,000 | 8,567,000 | 6,659,000 | 4,565,000 | 3,324,000 | 2,598,000 | 1,939,000 | 1,962,667 |
R&D Expenses | 5.4% | 148,086,000 | 140,441,000 | 130,225,000 | 117,838,000 | 107,431,000 | 94,923,000 | 84,255,000 | 56,998,000 | 52,311,000 | 50,435,000 | 48,113,000 | 41,506,000 | 37,014,000 | 32,077,000 | 27,014,000 | 24,479,000 | 19,390,000 | 15,027,000 | 11,888,000 | 9,233,000 | 8,894,667 |
EBITDA | - | - | - | - | - | -106,718,000 | -106,703,000 | -106,719,000 | -72,856,000 | -49,462,000 | -49,478,000 | -49,492,000 | -49,527,000 | -26,241,000 | -26,330,000 | -26,484,000 | - | - | - | - | - | - |
EBITDA Margin | - | - | - | - | - | -14.95 | -8.52 | -99.00 | -1,026 | -126 | -55.16 | -55.18 | -41.51 | -15.87 | -15.52 | -11.26 | - | - | - | - | - | - |
Interest Expenses | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 8,000 | 10,000 |
EBT Margin | - | - | - | - | - | -15.08 | -8.59 | -99.85 | -1,039 | -128 | -56.21 | -56.21 | -42.26 | -16.40 | -15.99 | -11.52 | - | - | - | - | - | - |
Net Income | -4.9% | -183,890,000 | -175,286,000 | -163,918,000 | -149,721,000 | -135,647,000 | -119,367,000 | -107,641,000 | -73,812,000 | -66,720,000 | -62,830,000 | -58,766,000 | -50,422,000 | -44,368,000 | -37,526,000 | -30,667,000 | -27,115,000 | -21,141,000 | -15,935,000 | -12,015,000 | -9,157,000 | -8,848,000 |
Net Income Margin | 100.0% | - | -40.91 | -34.60 | -27.88 | -19.00 | -9.53 | -99.85 | -1,039 | -170 | -70.04 | -65.51 | -42.26 | -26.84 | -22.13 | - | - | - | - | - | - | - |
Free Cashflow | 100.0% | - | -143,965,000 | -116,861,000 | -104,297,000 | -90,949,000 | -82,471,000 | -89,024,000 | -62,213,000 | -59,733,000 | -55,239,000 | -51,996,000 | -46,873,000 | -39,689,000 | - | - | - | - | - | - | - | - |
Balance Sheet | (In Millions) | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Description | (%) Q/Q | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 | 2018Q4 | 2018Q3 | 2018Q2 |
Assets | -6.6% | 293 | 314 | 352 | 385 | 422 | 333 | 351 | 209 | 217 | 164 | 183 | 200 | 217 | 124 | 130 | 143 | 155 | 167 | 171 | 177 | 75.00 |
Current Assets | -6.7% | 285 | 305 | 345 | 378 | 416 | 328 | 345 | 204 | 211 | 158 | 177 | 194 | 211 | 117 | 123 | 135 | 148 | 159 | 167 | 171 | 70.00 |
Cash Equivalents | -4.0% | 40.00 | 41.00 | 33.00 | 31.00 | 62.00 | 146 | 201 | 162 | 179 | 106 | 93.00 | 118 | 161 | 51.00 | 41.00 | 67.00 | 60.00 | 63.00 | 45.00 | 170 | 69.00 |
Net PPE | -1.3% | 3.00 | 3.00 | 4.00 | 4.00 | 3.00 | 3.00 | 3.00 | 3.00 | 3.00 | 3.00 | 3.00 | 3.00 | 4.00 | 4.00 | 4.00 | 4.00 | 4.00 | 4.00 | 4.00 | 4.00 | 2.00 |
Liabilities | 16.2% | 39.00 | 34.00 | 36.00 | 34.00 | 36.00 | 30.00 | 19.00 | 16.00 | 15.00 | 14.00 | 15.00 | 13.00 | 14.00 | 15.00 | 13.00 | 13.00 | 13.00 | 14.00 | 11.00 | 9.00 | 7.00 |
Current Liabilities | 23.9% | 33.00 | 26.00 | 28.00 | 25.00 | 26.00 | 20.00 | 16.00 | 12.00 | 12.00 | 10.00 | 10.00 | 9.00 | 10.00 | 11.00 | 8.00 | 8.00 | 8.00 | 9.00 | 8.00 | 6.00 | 6.00 |
Shareholder's Equity | -9.4% | 254 | 280 | 316 | 351 | 386 | 303 | 332 | 194 | 201 | 149 | 169 | 187 | 203 | 108 | 117 | 130 | 142 | 152 | 160 | 168 | - |
Retained Earnings | -10.5% | -536 | -485 | -439 | -394 | -352 | -309 | -275 | -244 | -216 | -190 | -167 | -146 | -127 | -111 | -93.80 | -79.25 | -64.82 | -52.40 | -43.38 | -34.88 | -27.30 |
Additional Paid-In Capital | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 204 | 202 | 2.00 |
Shares Outstanding | 1.3% | 55.00 | 54.00 | 54.00 | 54.00 | 53.00 | 48.00 | 48.00 | 38.00 | 37.00 | 33.00 | 33.00 | 30.00 | 31.00 | 24.00 | 24.00 | 24.00 | 24.00 | 24.00 | 12.00 | 20.00 | 2.00 |
Cashflow (Last 12 Months) | (In Thousands) | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Description | (%) Q/Q | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 | 2018Q4 | 2018Q3 | 2018Q2 |
Cashflow From Operations | -12.5% | -160,139 | -142,380 | -115,205 | -102,897 | -90,091 | -82,064 | -88,588 | -81,627 | -73,958 | -69,864 | -62,027 | -59,536 | -55,139 | -51,852 | -46,381 | -38,943 | -31,029 | -22,811 | -19,459 | -15,961 | -12,711 |
Share Based Compensation | 9.9% | 33,653 | 30,609 | 28,268 | 25,478 | 22,599 | 19,701 | 17,352 | 15,165 | 13,391 | 11,686 | 10,427 | 9,287 | 8,360 | 7,413 | 6,294 | 5,310 | 4,231 | 2,921 | 2,320 | 1,544 | 840 |
Cashflow From Investing | 251.3% | 123,866 | -81,841 | -173,980 | -312,631 | -326,478 | -132,369 | -56,483 | 36,423 | 18,616 | 16,380 | 217 | -3,714 | 41,566 | 33,407 | 41,667 | -64,191 | -84,890 | -94,802 | -119,458 | -1,008 | -775 |
Cashflow From Financing | -88.1% | 14,333 | 120,667 | 121,963 | 285,704 | 300,091 | 254,402 | 252,679 | 88,920 | 73,299 | 108,146 | 114,571 | 114,491 | 114,671 | 6,529 | 67.00 | 59.00 | 107,227 | 106,706 | 170,198 | 177,260 | 70,060 |
Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited) - USD ($) shares in Thousands, $ in Thousands | 3 Months Ended | 6 Months Ended | ||
---|---|---|---|---|
Jun. 30, 2023 | Jun. 30, 2022 | Jun. 30, 2023 | Jun. 30, 2022 | |
Income Statement [Abstract] | ||||
Revenues | $ 988 | $ 439 | $ 3,667 | $ 3,570 |
Operating expenses: | ||||
Research and development | 40,640 | 32,995 | 79,108 | 61,247 |
General and administrative | 13,343 | 10,489 | 25,532 | 19,195 |
Total operating expenses | 53,983 | 43,484 | 104,640 | 80,442 |
Loss from operations | (52,995) | (43,045) | (100,973) | (76,872) |
Other income (expense): | ||||
Interest income | 2,107 | 720 | 4,145 | 913 |
Other income (expense), net | (91) | (81) | (146) | (64) |
Change in valuation of derivative asset | 0 | 31 | 0 | 31 |
Total other income, net | 2,016 | 670 | 3,999 | 880 |
Loss before equity method investment | (50,979) | (42,375) | (96,974) | (75,992) |
Loss on equity method investment | 0 | 0 | 0 | (1,010) |
Net loss | $ (50,979) | $ (42,375) | $ (96,974) | $ (77,002) |
Net loss per share: | ||||
Net loss per share - basic | $ (0.94) | $ (0.81) | $ (1.79) | $ (1.54) |
Net loss per share - diluted | $ (0.94) | $ (0.81) | $ (1.79) | $ (1.54) |
Weighted average shares - basic | 54,275 | 52,522 | 54,092 | 50,130 |
Weighted average shares - diluted | 54,275 | 52,522 | 54,092 | 50,130 |
Other comprehensive income (loss): | ||||
Unrealized gain (loss) on investment securities | $ 809 | $ (1,427) | $ 2,226 | $ (3,237) |
Comprehensive loss | $ (50,170) | $ (43,802) | $ (94,748) | $ (80,239) |
Condensed Consolidated Balance Sheets - USD ($) $ in Thousands | Jun. 30, 2023 | Dec. 31, 2022 |
---|---|---|
Current assets: | ||
Cash and cash equivalents | $ 39,553 | $ 32,672 |
Investment securities | 224,976 | 301,753 |
Prepaid expenses and other current assets | 20,281 | 10,759 |
Total current assets | 284,810 | 345,184 |
Property and equipment, net | 3,223 | 3,500 |
Operating lease right-of-use asset | 1,253 | 1,486 |
Derivative asset | 668 | 668 |
Restricted cash | 1,300 | 1,301 |
Other assets | 2,000 | 37 |
Total assets | 293,254 | 352,176 |
Current liabilities: | ||
Accounts payable and accrued expenses | 20,825 | 15,351 |
Accrued compensation and related expenses | 8,596 | 9,081 |
Deferred revenue | 2,080 | 2,240 |
Operating lease liability | 1,109 | 1,051 |
Total current liabilities | 32,610 | 27,723 |
Operating lease liability, non-current | 1,456 | 2,024 |
Deferred revenue, non-current | 5,072 | 6,101 |
Total liabilities | 39,138 | 35,848 |
Commitments and contingencies (Note 7) | ||
Stockholders’ equity: | ||
Preferred stock, $0.001 par; 10,000 shares authorized; no shares issued or outstanding on June 30, 2023 or December 31, 2022 | 0 | 0 |
Common stock and paid-in capital, $0.001 par; 200,000 shares authorized; 54,682 shares issued and outstanding on June 30, 2023; 53,877 shares issued and outstanding on December 31, 2022 | 791,968 | 759,432 |
Accumulated other comprehensive loss | (1,705) | (3,931) |
Accumulated deficit | (536,147) | (439,173) |
Total stockholders’ equity | 254,116 | 316,328 |
Total liabilities and stockholders’ equity | $ 293,254 | $ 352,176 |